Fidelity Advisor Biotechnology Fund REGN Holdings History
Fidelity Advisor Biotechnology Fund's Regeneron Pharmaceuticals Inc Holding Summary
As of 2025-04-30, FIDELITY ADVISOR SERIES VII held 150,000.00 shares of Regeneron Pharmaceuticals Inc(REGN), totaling $89.81 Mil. This investment constitutes 6.61% of their stock portfolio, and FIDELITY ADVISOR SERIES VII now holds 0.14% of the outstanding Regeneron Pharmaceuticals Inc(REGN) stock.
The initial trade took place in 2020Q1. And since then Fidelity Advisor Biotechnology Fund has made 8 purchases of REGN, at an average price of $716.01, for a total of 1.59 Mil shares. In addition, there have been 12 sales at an average price of $695.19 for 1.44 Mil shares. Based on historical transaction data and REGN's current price of $551.03, Fidelity Advisor Biotechnology Fund's estimated gain on his REGN holdings is $-54.67 Mil, reflecting a -4.81% gain to date.
Fidelity Advisor Biotechnology Fund REGN ($551.03) Holding Chart
Fidelity Advisor Biotechnology Fund REGN ($551.03) Quarterly Buys and Sells
| Period | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Avrg. Price |
|---|---|---|---|---|
| Shares Bought | 0 | Average Price $-/Share | ||
| Shares Sold | 0 | Average Price $-/Share | ||
| Current Price $0.00 | Total Estimated Gain 0 % | |||
Top Ranked Articles
- 1
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
